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Blood-contacting cardiovascular stents often induce a secondary clotting event 
due to unrestricted enzymatic activities. The use of hemocompatible polyurethane 
coatings on these implantable devices is one of the most promising methods to reduce 
device rejection. In this study, four commercial polyurethane films of various thicknesses 
and compositions were evaluated for their anticoagulation properties. Results suggested 
that these films exhibited excellent thermal and physico-mechanical properties while 
capable of increasing contact time with blood plasma by over a thousand-fold as 
compared to a control surface. Due to the unknown structure and composition of these 
commercial films, polyurethane samples were synthesized from toluene diisocyanate as 
the hard segment and polyethylene glycol as the soft segment under various hard-to-soft 
segment ratios. The synthesized samples were cast into films for testing of their physico-
mechanical properties. The effects of the hard-to-soft segment ratios on these properties 
and the synthesis process were evaluated in order to optimize them for use in 
anticoagulation coatings.
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Chapter 1: Introduction 
With the many diseases and disabilities faced in the medical field today, one of 
the most common and serious occurrences is blood clotting. Venous thromboembolisms 
(VTE), which are clots that form in blood veins, affects 300,000-600,000 people per year 
in the US and kills roughly 90,000 of those affected [1]. Operations for this can be quite 
costly as well, as the average operation cost to remove a deep vein clot is $10,000. In 
fact, clot removal operations can range in cost from $1,000-$100,000 per operation, 
depending on the severity and location of the clot, and there is typically a 10-50% copay 
with insurance [2]. One contributing factor is heart disease, which affects 28.2 million 
adults in the US or 11.5% of the adult population and is the #1 cause of death in the US, 
claiming 650,000 lives per year [3]. Other related factors include implantable devices 
such as cardiovascular stents, 1.8 million of which are implanted in the US per year at a 
cost of $35,000-$40,000 per operation and 10-20% with insurance [4,5]. 
Depending on the severity of the clot, a number of treatments are available. If it is 
not too serious, a doctor may prescribe medication, such as heparin, or advise the use of a 
compression wrap [6]. More serious clots or those in vital areas will require an operation. 
For those vital areas, one of the most popular options is the implantation of a vascular 
stent, which is inserted into the blocked blood vessel to help blood flow freely. Vascular 
stents act as structural support during the regrowth of the endothelial cells that coat the 
walls of vessels and are capable of other functions, such as drug delivery. However, 
inserting foreign objects into the body can have very serious consequences, namely the 
activation of the coagulation cascade, which is the process of clot formation that is 
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normally activated to make repairs to damaged areas. It can be life-threatening for a 
patient as it is also capable of closing off blood flow to major arteries and vessels.  
One of the most attractive and innovative methods for solving this issue is the use 
of a hemocompatible coating along the surface of these devices to minimize the 
possibility of the clotting process to be activated [7]. Several types of coatings have been 
examined for this use and one of the most promising is polyurethane coatings [8]. 
Polyurethanes are created by mixing a soft segment, consisting of a polyol, and a hard 
segment, made from a combination of a diisocyanate and a low molecular weight diol or 
diamine, at specific stoichiometric ratios [9]. The functional groups of each segment, OH 
groups for the soft segment and NCO groups for the hard segment, combine to form 
NCOOH urethane bonds, the formation of which can be seen using FTIR analysis 
[10,11]. The ratio of the hard-to-soft segments has a large impact on the properties of the 
polyurethane. Therefore, the purpose of this work is to study the effects of the ratio of the 
components used to synthesize the PU samples on the synthesis process and the physico-
mechanical properties of the samples. This is done to help optimize the properties of the 
PU for use as anticoagulation coatings on implantable medical devices. 
In this work, currently available coatings are compared, and polyurethane (PU) 
coatings show promising potential. Therefore, four commercial PU films, two polyester 
urethane films and two polyether urethane films of various thicknesses and shore 
hardness, were purchased. The physical appearance of the films was determined, then the 
chemical structure of the PU films was evaluated using Fourier-transform infrared (FTIR) 
spectroscopy. Next, the thermal properties of these films were determined through the use 
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of differential scanning calorimetry (DSC) and thermal gravimetric analysis (TGA) as 
well as their crystallinity by using X-ray diffraction (XRD) technique. The physico-
mechanical properties of the PU films were then determined by water contact angle and 
water absorption/degradation studies along with tensile testing. Lastly, in vitro clotting 
assays were performed using human blood plasma on the various PU films to determine 
their anticoagulant properties. Based on the results of this testing, an ester-based 
polyurethane that could be synthesized with a simple laboratory setup was developed and 
several samples of various composition ratios were successfully synthesized. The 
physico-mechanical properties of these films were then evaluated to determine the effects 
of the ratios and their viability as anticoagulation coatings on implantable medical 
devices. 
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Chapter 2: Significance 
The significance of this thesis work is the early steps towards producing an 
anticoagulation coating that will significantly reduce the chance of implanted biomedical 
devices to be rejected in the body over a long period of time. While there are 
commercially available anticoagulation films currently available, the films created for 
this work are unique. Currently used films are able to delay the clot formation process for 
years, but many of them are designed to break down and release drugs that aid in 
preventing clotting. Once these films completely break down, the risk of clotting will 
again become significant. While this may be fine for patients who unfortunately only live 
for a few years after receiving an implanted device, others may live for twenty or more 
years after receiving the implant. In order to improve their quality of life and potentially 
extend their lifespan, it is imperative that a longer-lasting solution be found. 
The uniqueness of this work is that the films synthesized were designed with 
longevity in mind. Polyurethanes were used as the base of these films because they are 
both naturally versatile and easily modified. There are plenty of options available to use 
for the soft and hard segments with several studies done on the biocompatibility of many 
of the materials, as well as on surface modifications that can be made to polyurethane 
films in order to significantly change certain properties. None of the currently available 
coatings have been found to last more than a few years after implantation, therefore, 
designing a new coating and modifying it appropriately to prevent clotting over a much 
longer period of time without the use of drugs would be a significant improvement over 
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available commercial options for anticoagulation coatings on implantable biomedical 
devices. 
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Chapter 3: Literature Review 
3.1 Clotting Cascade 
In order to establish whether a polymeric coating can be an effective tool for 
anticoagulation, it is necessary to first understand how the body will react when 
introduced to these materials [12]. There are two paths through which the clotting process 
commences, the tissue factor pathway and the contact pathway. The tissue factor pathway 
is the natural process by which the body heals itself of injuries, like cuts to the skin. The 
contact pathway is activated when foreign objects, such as implantable medical devices, 
come into contact with the blood. This contact triggers a change in the structure 
(activation) of a plasma protein called factor XII, which becomes active factor XII (XIIa). 
The presence of XIIa then activates the enzyme plasma prekallikrein (PK) into kallikrein, 
which further activates XII, leading to a mass production of XIIa. Factor XIIa then 
activates the enzyme factor XI into XIa, which breaks down the protein factor IX into 
IXa through proteolysis, which then activates factor X into Xa. Once factor Xa is finally 
triggered by the flood of other enzymes and proteins in the blood that are activated during 
the coagulation cascade, the process concludes with the generation of the enzyme 
thrombin, which polymerizes the protein fibrinogen into fibrin and the activation of 
platelets, both of which form blood clots [13–15].  
The reason that this cascade occurs is that blood is usually only in contact with 
the walls of the vessels that carry them through the circulatory system. These vessels are 
coated with endothelial cells, which perform a range of useful functions when healthy, 
including the prevention of clotting. The clotting cascade, which is visually represented 
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in Figure 1, begins when these cells are damaged, as the damaged surface becomes 
thrombotic [16]. 
 
Figure 1. Schematic illustration of the blood clotting cascade. 
 
Seeing as implantable devices are not coated with a layer of endothelial cells, the 
body considers them to be a damaged vessel surface and will begin the clotting process to 
attempt to repair it. However, unlike the normal process of forming clots inside holes 
along the surface of a vessel, clots will begin to form on the outside surface of the 
biomaterial. This not only raises the risk that the implanted device will fail but could 
potentially be very harmful or even fatal to the recipient, as this could cause the blood 
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flow in vessels and arteries to be entirely cut off. One possible solution that researchers 
are looking at to prevent this is the use of anticoagulant coatings for implantable devices. 
3.2 Anticoagulation Coatings  
3.2.1 Biocompatibility 
When determining the suitability of biomaterials for anticoagulation, 
biocompatibility is one of the most important factors to consider. The key aspects that 
must be examined before the use of a biomaterial is considered are: is the body going to 
immediately attack or reject the material, can the material cause the formation of tumors 
in the neighboring tissue, and is the material prothrombotic [17]. As the last factor is the 
basis of finding suitable coatings for anticoagulation, the other factors are the more 
crucial problems to consider.  
3.2.2 Coatings that Improved Existing Devices 
Of the many implantable devices currently in use, one that could seriously benefit 
from the addition of improved anticoagulation coatings is the cardiovascular stent. Stents 
are routinely used to hold clogged arteries open to allow for better blood flow, with the 
most frequently used types of stents being bare metal stents and drug-eluting stents. Bare 
metal stents are meshes composed of different types of metals and alloys that can be 
expanded inside a vessel, and drug-eluting stents, which are made of the same mesh 
material, also include a biodegradable polymeric coating that breaks down and releases 
anticoagulation and antiproliferative agents into the blood over time [18].  
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Thanks to the addition of the biodegradable coating, drug-eluting stents are 
considered to be the safer option, as they have been proven to have a lower risk of 
causing clot formation. However, the coatings used on these stents only last a few months 
before they dissolve completely. This means that clots can still form over time inside 
these stents, even in combination with double antiplatelet therapy, which helps to further 
prevent clot formation [19,20]. To reduce the possibility that clotting occurs, the coatings 
for these stents need to either dissolve at a much slower rate or have the ability to 
administer the drug without dissolving the polymer entirely.  
3.2.3 Polymeric Coatings 
Heparin, an excellent anticoagulant drug that is also effective for controlling 
immune defense and cell growth has been one of the most popular methods for avoiding 
thrombosis for decades. Grafting or ionically attaching heparin to the surface of a 
polymer coating can significantly increase its effectiveness at preventing clots, and 
coatings with heparin attached have been shown to reduce clot formation by over 70% 
[18]. However, as effective as heparin use can be, it has a few disadvantages. In addition 
to being a great anticoagulant, it is also a blood thinner, which raises the chance for 
severe bleeding to occur. Also, heparin-induced thrombocytopenia (HIT), a possible side 
effect due to repeated use of heparin, is a prothrombotic disorder that can increase the 
risk that clots form around the coated device [21].  
This has led to the development of synthetic polymer coatings meant to mimic the 
anticoagulant properties of heparin without the side effects, which could be especially 
beneficial for patients that rely on the drug, such as those going through dialysis 
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treatments. This was done by finding the chemical properties that are believed to the 
basis for heparin’s clot prevention abilities, the presence of abundant sulfate or carboxyl 
groups, and creating polymers with similar chemical structures. Wang et al. coated a 
polylactide (PLA) membrane with one of these heparin-mimicking polymers synthesized 
with methylacrylic acid (MAA) and ethylene glycol diacrylate (EGDA) and noted that 
the coated membranes were capable of mimicking the effects of heparin, as the 
membranes exhibited extended clotting times and reduced platelet adhesion [21].  
Polyurethanes are another type of polymeric coating that is becoming more 
popular for potential anticoagulant coating applications, thanks in part to the ease of 
modification to these polymers. Chi et al. [22] purchased a commercial polyurethane film 
and modified it with 2-methacryloyloxyethyl phosphorylcholine (MPC). Results obtained 
from testing displayed enhanced resistance to platelet adhesion, increased hydrophilicity, 
and only a very small amount plasma calcium was able to be retrieved during clotting 
trials, even after multiple tests. All of these properties show very promising potential for 
anticoagulation, however, the reasons for the film’s excellent properties could not be 
explained. If these results prove to be reliable, then the anticoagulation properties of this 
modified polyurethane film are phenomenal [22].  
Other trials using modified polyurethane films have not proved as successful. 
Graphene and tricalcium phosphate (TCP) were added during the production of a 
polyurethane composed of polyethylene glycol (PEG), 4,4′‐ diisocyanate 
diphenylmethane (MDI), and 1,4‐butanediol (BDO) as a chain extender that was going to 
be used to coat titanium plates. The focus of the testing performed was aimed more 
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towards the film’s antibacterial properties and found that using 4wt% graphene in the 
polymer made the coating cytotoxic, making it worthless for the intended purpose. Lower 
amounts of graphene, such as 0.25 wt%, did not have the same effect, but for this 
combination to be considered for use as a biomaterial, it will need to be tested further 
[23].  
Amoako et al. [24] devised a creative idea for an anticoagulant coating and 
attempted to “create an artificial endothelium by coupling anti-fouling zwitterionic 
functional groups, similar to those expressed by endothelial cells, with anti-platelet 
nitrous oxide, which is released by endothelial cells.” Their hypothesis was that the 
combination of these methods would result in a highly effective coating, and the 
reduction of platelet adsorption by over 90% obtained during testing proved their 
hypothesis [24]. 
Other variations and combinations of these methods have been attempted to help 
improve current anticoagulation coatings. Non-eluting heparin coatings, graphene oxide 
on titanium, and graphene with heparin attached have all been recently explored as 
potential options [25,26]. These options, however, do not resolve the issues of the 
individual methods, as the possible cytotoxicity of graphene and HIT caused by frequent 
heparin use are still possible consequences of using these materials [21,23].  
3.2.4 Non Polymeric Coatings 
Non-polymeric options have also been explored for anticoagulant purposes. 
Metal−phenolic/catecholamine coated onto a stainless-steel rod exhibited good 
anticoagulant, antibacterial, and anti-inflammatory properties, thanks to the catalytic 
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release of nitrous oxide. The problem with this type of coating is that, while the coating 
continuously released nitrous oxide throughout testing, the reaction will not continue 
forever, and the potential duration of the reaction was not noted. Therefore, while it may 
work for short-term treatments, it is not yet suitable for coatings on implantable devices 
meant to last indefinitely [27].  
A multifunctional coating, composed of hyaluronic acid and polydopamine, has 
also been examined, with the purpose of having good properties for anticoagulation, 
antihyperplasia, anti-inflammation and endothelialization. This is because these processes 
tend to contradict each other [28]. The coating was successful in showing good potential 
in all of the categories required, however, it has the same problem as the previous 
coating, as its anticoagulant properties are reliant on the release of nitrous oxide, which is 
not yet suitable for indefinite applications.  
Of the non-polymeric options for anticoagulant coating, ultrananocrystalline 
diamond (UNCD) is easily one of the most fascinating and promising. Though it seems 
difficult to manufacture, this inexpensive coating has exhibited phenomenal 
anticoagulation properties. In comparison to the pyrolytic carbon, which is what most 
mechanical heart valves are composed of, both materials showed clot formation levels 
similar to a control, and the mechanical properties of UNCD are far superior to that of 
pyrolytic carbon for the intended application [29,30]. The main disadvantage of UNCD is 
that, although it is inexpensive, is the possible difficulty of production. The advantages 
and disadvantages of UNCD are compared to that of all other coatings described in Table 
1. 
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3.2.5 Surface Modifications to Coatings 
One of the key factors to consider when reviewing any material for potential use 
in anticoagulant coatings on implantable medical devices is the material’s surface 
properties, as the material will be in direct contact with the blood. Surface properties 
include the material’s hydrophobicity, protein adsorption, formability, and many others 
capable of being manipulated in numerous ways, including plasma treatment, chemical 
vapor deposition, and grafting. When deciding on potential materials for use in coatings 
for anticoagulation, suitable surface modifications should be evaluated in order to 
maximize the coating’s potential effectiveness [30–34]. 
 
Table 1. Summary of current anticoagulant coatings. 
Coating Materials 
Anticoagulation 
Mechanism 
Approximate 
Effective Life 
Pros Cons [Ref] 
Drug-Eluting 
Stent Coating 
Polymeric Drug Release 
6 to 12 
Months 
Proven 
Effectiveness 
Only lasts a 
few months 
before 
dissolving 
[18-
20] 
Heparin-
Coated Film 
Polymeric Heparin 
Up to 2 
Months 
Very Effective 
Increases 
bleeding risk, 
chance of 
developing 
HIT 
[18, 
21] 
Heparin-
Mimicking/H
eparin-Free 
Coating 
Polymeric 
Materials with 
plentiful 
carboxyl or 
sulfate groups 
Varied, >2 
Months 
Effective, Low 
Health Risk 
Not as 
effective as 
heparin due to 
lack of 
knowledge for 
heparin's 
effectiveness 
[21] 
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Coating Materials 
Anticoagulation 
Mechanism 
Approximate 
Effective Life 
Pros Cons [Ref] 
Polyurethane 
Films 
Polymeric 
Surface 
Properties 
Varied 
Very 
Effective, 
Highly 
Modifiable 
Not enough 
research for 
this type yet, 
room for 
improvements 
[22] 
Polyurethane/
Graphene/TC
P Coating 
Polymeric N/A N/A 
Antibacterial 
Properties, 
Good 
Mechanical 
Properties 
Becomes 
cytotoxic at 4 
wt% graphene 
[23] 
Artificial 
Endothelium 
Polymeric 
Zwitterionic, 
Nitrous Oxide 
Release 
Not enough 
long-term 
data 
Very Effective 
NO release 
may not last 
[24] 
Heparin/Grap
hene Coating 
Polymeric Heparin 
Up to 2 
Months 
Effectiveness 
of Heparin and 
Antibacterial 
Properties of 
Graphene 
Possibility for 
cytotoxicity, 
bleeding risk, 
and 
development 
of HIT 
[25, 
26] 
Metal−Pheno
lic/ 
Catecholamin
e Coating 
Non-
Polymeric 
Nitrous Oxide 
Release 
Not enough 
long-term 
data 
Anticoagulant, 
Antibacterial, 
and Anti-
Inflammatory 
Properties 
NO release 
may not last 
[27] 
Hyaluronic 
Acid/ 
Polydopamin
e Coating 
Non-
Polymeric 
Nitrous Oxide 
Release 
Not enough 
long-term 
data 
Anticoagulant, 
Antihyperplasi
a, and Anti-
Inflammatory 
Properties 
NO release 
may not last 
[28] 
Ultrananocrys
talline 
Diamond 
Coating 
Non-
Polymeric 
Surface 
Properties 
>4 Weeks, 
not enough 
long-term 
data 
Very 
Effective, Low 
Cost, Good 
Mechanical 
Properties 
Seemingly 
difficult to 
produce 
[29, 
30] 
 
15 
 
3.2.6 Polyurethanes 
Of these coatings, one of the most promising options are polyurethanes (PUs). 
Polyurethanes are utilized extensively in various biomedical applications due to their 
excellent biocompatibility [35,36] and slow degradability [11,37,38]. They are produced 
using a variety of processes with structural components containing alternating soft 
segments (polyols) and hard segments (diisocyanates) at specific stoichiometric ratios, 
depending on the desired properties of the PUs [9]. A polyurethane is formed when a soft 
segment, containing hydroxyl groups (OH), and a hard segment, containing isocyanate 
groups (R-NCO), are combined together to form urethane linkages (-NHCO-) [10].  
PUs are elastomers, meaning they have high tensile strength, are highly elastic, 
and have low crystallinity [39]. The combination of these properties and the excellent 
biocompatibility has led to a widespread research into its viability in biomedical 
applications. PU films have been shown to be an excellent option for various medical-
grade applications, such as for protective coatings on implantable devices [40]. Another 
capability of PUs is drug delivery, where the polymer will either degrade to deliver drugs 
to a patient or have drugs eternally attached so that they will directly degrade into the 
body over time [41]. Similarly, PU films have displayed excellent anticoagulant 
properties, which makes them very practical as anticoagulant coatings to prolong the 
lifespan of implantable devices [22]. Others have synthesized PUs to create porous 
scaffolds that can be used to repair or replace damaged organs or tissues [42]. 
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Chapter 4: Materials and Methods 
4.1 Materials 
Polyethylene Glycol (PEG, MW 3400) was purchased in powder form from MP 
Biomedicals, LLC, and was chosen as the soft segment for its excellent biocompatibility. 
An 80/20 mixture of 2,4- and 2,6- Toluene Diisocyanate (TDI) was purchased in liquid 
form from VWR International, LLC, and was chosen as the hard segment for the 
mechanical properties it produces. N,N-Dimethylformamide (DMF) was purchased in 
liquid form from VWR International, LLC, and was used as the solvent to dissolve the 
PEG prior to synthesis. 1,4-Butanediol (BDO) was purchased in liquid form from VWR 
International, LLC, to be used as a chain extender. 
4.2 Preparations of Polyurethane Commercial Films 
In order to examine the viability of polyurethane films for use in anticoagulant 
coatings and the properties of different types and thicknesses of PU films, four sets of 
commercial films were purchased from Jiaxing Inch Eco Materials Co., Ltd. (Zhejiang, 
China). These films included 0.06 mm and 0.1 mm polyester films (60ES and 100ES) 
and 0.06 mm and 0.2 mm polyether films (60ET and 200ET). 
4.3 Synthesis of Polyurethane Samples 
 To synthesize each sample of polyurethane, a 15 wt% mixture of 1.2 g of PEG in 
8 mL of DMF is first made and is mixed until all PEG is dissolved. The mixture is then 
placed inside a fume hood and into a water bath on a hot plate set to 70°C, and TDI is 
slowly added to the mixture. A magnetic stir bar is then added, and the solution is mixed 
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for up to 3 hours. The amount of TDI added and the time that the solution is mixed 
depends on the desired ratio of hard-to-soft segments of the polyurethane. 2 wt% of the 
chain extender BDO was added to some samples as well, after the TDI was able to mix. 
The laboratory setup for the synthesis process can be seen in Figure 2. 
 
Figure 2. Laboratory setup for polyurethane synthesis, thermometer is included in beaker 
due to an inaccurate hot plate temperature. 
 
 Once the solution has been mixed and the release of CO2 from the reaction has 
ended, the solution is quickly poured into a flat mold and allowed to dry for 6 hours in 
order to create a film. To measure the yield mass of each ratio, the solutions were allowed 
to cool for 30 minutes, then poured into a beaker of water to precipitate the polymer, as 
shown in Figure 3. The solid polyurethane sample is removed from the water and allowed 
to dry overnight, then the yield mass is recorded. 
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Figure 3. Visual representation of the precipitation process of the polyurethane samples. 
 
4.4 Fourier-Transform Infrared Spectroscopy (FTIR) 
The chemical structure of several polyurethane samples was analyzed using a 
Thermo Fisher Scientific Nicolet iS10 ATR-FTIR spectrophotometer (Walthem, MA, 
USA). The spectra were collected between 4000 and 650 cm-1 with a resolution of 8 cm-1. 
Information for the peaks of the samples was obtained using OMNICTM software. 
4.5 Differential Scanning Calorimetry (DSC) 
A Shimadzu DSC-50 (Kyoto, Japan) was utilized to examine the crystallinity, 
glass transition, and melting temperatures of the PU samples at a scanning rate of 20 
°C/min between 25 and 200 °C. The weight of the specimens ranged between 6 and 10 
mg. Three separate measurements were made for each sample, and the results were 
averaged. 
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4.6 Thermal Gravimetric Analysis (TGA) 
Changes in the mass of the samples during thermal decomposition were explored 
through thermal gravimetric analysis using a Shimadzu TGA-50 Thermal Analyzer 
(Kyoto, Japan). The heating rate was 20 °C/min from 10 to 650 °C under N2 gas with a 
flow rate of 30%. The weight of tested sample ranged between 15 and 18 mg. Three 
separate measurements were made for each sample, and the results were averaged. 
4.7 X-Ray Diffraction (XRD) 
The diffraction patterns of several PU samples were collected using a Rigaku R-
Axis SpiderTM (Tokyo, Japan). The x-ray source was produced from copper Kα 
wavelength (λ = 1.541 Å) at a 40 kV voltage and a current of 40 mA. The diffractometer 
was used in reflection mode. The XRD data was recorded at a resolution of 2θ = 0.05 
degree, from 2θ = 4 to 40 degrees. 
4.8 Water Contact Angle and Water Absorption 
The surface hydrophilicity of several PU samples was determined by water 
contact angle measurements. A single droplet of phosphate-buffered saline (4 μL) was 
added to the surface of each sample, and the water contact angle was determined using 
ImageJ (National Institutes of Health, Bethesda, MD, USA) software. Three separate 
measurements were made for each sample, and the results were averaged. 
Water absorption data was acquired by submerging 1” diameter disks of each PU 
sample into 3 mL of phosphate-buffered saline for up to 2 weeks. The submerged disks 
were placed in an incubator at 37°C under continuous shaking. At fixed time intervals, 
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the PU disks were removed from the saline and carefully dried to record the mass. 
Percent weight change in water content was calculated using the equation below, 
%𝑊𝑒𝑖𝑔ℎ𝑡 𝐶ℎ𝑎𝑛𝑔𝑒 =  
𝑊𝑡 − 𝑊𝑖
𝑊𝑖
 ×  100% 
where Wi is the initial dry weight and Wt is the dry weight at each time interval. Three 
separate measurements were made for each sample, and the results were averaged. 
4.9 Mechanical Testing 
An Instron 3340 universal mechanical tester (Norwood, MA, USA) was used for 
the tensile testing of the PU samples, and testing was performed according to ASTM 
standard D882-18 (e.g., 23 ± 2 °C and 50 ± 5% RH) [43]. The samples were cut into a 
dog-bone shape according to ASTM standard D1708-96 (22 mm in nominal length and 5 
mm in width) [44]. Tensile tests were conducted at a strain rate of 0.01/s using a 100 N 
load cell. Stress-strain curves were generated using the raw load and displacement data 
obtained during testing. The elastic modulus was determined using the initial slope of the 
stress-strain curve after tensile testing. The tensile strength was obtained by dividing the 
maximum applied load to the cross-sectional area of the films. The elongation to failure 
was acquired from the stress strain curve at the strain (%) at which the specimen was split 
in two. Three separate measurements were made for each sample, and the results were 
averaged. 
4.10 Clotting Assays 
Two forms of in vitro activated partial thrombin time (APTT) assays were 
measured using an Organon Teknika Coag-A-Mate®XM (Durham, NC, USA). The 
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surfaces of each sample and all equipment used were washed using a mixture of typical 
household detergents and ethanol (75%) before each clotting experiment. Coagulation 
times were obtained as follows: 
(1) 150 μL of plasma was placed into a test tube along with 40 μL of CaCl2. The 
solution was thoroughly mixed and then applied to the surfaces of a glass plate (contact 
activation positive control) and each of the PU samples to be taken out at intervals of 0, 
7, 10, 14, 17 and 22 minutes (contact time). At each interval, 100 μL of the plasma/CaCl2 
sample was then put into the Coag-A-Mate®XM and was activated immediately, utilizing 
this step as a warming process, with a time of 3 minutes. An additional 100 μL of CaCl2 
was added to the plasma/CaCl2 sample and clot formation was then recorded (clotting 
time). Three separate measurements were made for each sample, and the results were 
averaged. 
(2) 700 μL of plasma was placed into test tubes containing the control (glass 
beads) or shredded square PU samples with an estimated surface area equivalent to the 
glass beads. At fixed time intervals, 100 μL of the plasma was removed from the test tube 
and 40 μL of CaCl2 was added before being placed into the Coag-A-Mate®XM for 
activation. An additional 100 μL of CaCl2 was added to the plasma/CaCl2 mixture and 
clot formation time was then recorded. 
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Chapter 5: Results and Discussion 
5.1 Commercial PU Films 
5.1.1 Appearance 
Four samples of commercial PU films, 60ES, 100ES, 60ET, and 200ET, were 
physically examined by eye. The films, which can be seen in Figure 4, displayed no 
differences in their appearance and texture and were clear of noticeable flaws, such as 
cracks and air bubbles. The thicker films (i.e., 100ES and 200ET) were opaquer than their 
thinner counterparts (i.e., 60ES and 60ET). For the duration of the study, the films were 
stored under typical laboratory conditions (e.g., 23 ± 2 °C and 50 ± 5% RH) and 
exhibited no signs of degradation and/or changes in appearance. 
 
Figure 4. Physical appearance of the four commercial PU films: from left to right in the 
top wells, 200ET, 100ES, 60ES, and 60ET. The second row of 4 wells contains no PU 
films for comparison of the transparency of the PU films. 
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5.1.2 FTIR 
FTIR spectroscopy is a nondestructive material characterization technique that 
can be utilized to quantitatively examine the chemical structure of polymers. For 
example, FTIR analysis has been used to study the physical state of pharmaceutical 
solids, including the amorphous/crystalline phases and the degree of crystallinity, based 
on the intensities of the characteristic peaks [45]. FTIR is also very useful when studying 
the urethane linkage (–NHCO–) along with the composition of the soft segments in PU, 
such as ether (R–O–R’) or ester (R–COO–R’) [46,47]. Therefore, in this section, FTIR 
spectroscopy is utilized to determine the chemical structure of each of the PU samples. 
The FTIR spectra of the commercial PU films exhibited a strong peak at 3330 cm-1, 
which is assigned to the stretching vibration of N–H groups in the urethane linkage 
(Figure 5a) [48]. This N–H peak, which was noticeable for each PU samples, was 
somewhat overlapping with the O–H stretching peak at 3400 cm-1, which can typically be 
attributed to the presence of moisture in the air or within the sample. Nonetheless, the O–
H stretching peak was generally broader than the N–H peak with less relative intensity 
when compared to other characteristic peaks in the 1000 cm-1 to 1600 cm-1 region [49]. 
Furthermore, the frequency of N–H stretching vibration tended to shift toward 3400 cm-1 
depending on the conformation of the urethane linkages with respect to one another under 
intermolecular hydrogen bonding. For example, the bands at 3325 cm-1 and 3313 cm-1 
were associated with intramolecular hydrogen bonding of N–H and C=O within the 
urethane linkage, whereas the bands at 3440 cm-1 and 3451 cm-1 were attributed to the 
intermolecular hydrogen bonding [50]. Specifically, the intermolecular hydrogen bonds 
24 
 
in PU formed at the carbonyl groups in urethane linkage of the hard segments and/or at 
the carbonyl groups (ester) or oxygen (ether) groups in the soft segments [51]. For 
poly(ester-urethane), the competition of hydrogen bonding between the carbonyl groups 
of the hard segments and the soft segments determined the molecular configurations [52]. 
The ability to form hydrogen bonds was critical to the surface polarity and 
hemocompatibility of the PU as aliphatic PUs (all N–H groups are hydrogen bonded) 
tended to be more hydrophilic than aromatic PUs [53]. 
Further analysis of the FTIR spectra from the PU films suggested the 
characteristic peaks at 1700 cm-1, 1531 cm-1, and 1314 cm-1 due to C=O stretching 
vibration (amide I band), N–H bending vibration (amide II band) and C–N (amide III 
band) stretching vibration, respectively (Figure 5b) [48]. Additionally, the peak at 
1597cm-1 indicated the skeletal vibration of C=C in the aromatic ring [54]. The 
evidence of the aromatic ring conformation in various PU samples was supported by 
the coupling peak at 814 cm-1, the most significant characteristic peak for out of 
plane bending vibration of C–H in 1,4-disubstituted aromatic ring [55]. This finding 
suggested the chemical structure of hard segment in the PU films consisted of 
aromatic polymer, such as diisocyanates [56]. In comparison, the absorbance 
between 2930 and 2860 cm-1 (C–H stretching vibrations) coupled with the 
characteristic band patterns at 1200 and 1100 cm-1 were the characteristic 
absorptions of C–O–C stretching vibrations, indicating the composition of esters and 
ethers, respectively, in the soft segments of the various PU samples [54]. 
25 
 
 
Figure 5. FTIR spectra of the various commercial PU films for: (a) wavenumbers from 
650 cm-1 to 4000 cm-1 showing the characteristic peaks of N–H stretching vibration at 
around 3300 cm-1 and C=O stretching vibration from amide I band at around 1700 cm-1; 
(b) wavenumbers from 1000 cm-1 to 1600 cm-1 showing the characteristic peaks of N–H 
bending vibration from amide II band at around 1531 cm-1 and C–N stretching vibration 
from amide III band at around 1314 cm-1 that form the urethane linkage (–NHCO–). 
 
5.1.3 DSC 
According to the FTIR spectra, the commercial PU films consist of hard segments 
of diisocyanates and soft segments from esters and ethers, where the two segments are 
phase separated. DSC is useful when measuring the phase transition temperatures of the 
two phases. In particular, the glass transition temperature of the soft segments occurs at 
around -45°C to -50 °C, and this thermal event is used to evaluate the purity of the soft 
phase [57,58]. Due to the limitations of available instruments, DSC measurements were 
conducted on the various PU films from 25°C to 200°C to focus on the thermal events 
above room temperature. 
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The representative DSC thermograms from the PU films are displayed in Figure 
6. As shown in the figure, 200ET samples showed a thermal endotherm at 55.1 ± 1.3°C, 
corresponding to melting of the soft segments. This thermal event was not visible in the 
other PU samples, suggesting that the 200ET comprised a different of degree of 
crystallinity in the soft segments than the other PU samples [59]. This finding was in 
agreement with the supplier’s manufacturing of PU samples where the 200ET samples 
were processed in a different batch. 
As temperature increases, a small thermal endotherm was found at 124.1 ± 2.8°C, 
123.7 ± 3.2°C, 119.8 ± 7.2°C, and 126.7 ± 2.5°C for 60ES, 100ES, 60ET, and 200ET, 
respectively. This thermal event is associated with the melting of hard segments that have 
long range ordering [58]. In particular, the 60ES and 100ES groups showed several other 
small thermal endotherms between 120°C and 175°C, suggesting that the poly(ester 
urethane) displayed a mixing of crystalline regions with various range of ordering 
[60,61]. Finally, the thermal endotherms between 175°C and 200°C were associated with 
the melting of the microcrystalline hard segments. In general, the DSC thermograms 
informed the melting of the hard and soft segments and the crystallinity of the various PU 
films. An increase in the crystallinity of the film increases the temperatures of the 
corresponding thermal events. 
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Figure 6. DSC thermograms of the various PU films from 25°C to 200°C, where a 
thermal endotherm at approximately 50°C for the 200ET groups corresponds to melting 
of the soft segments. 
 
5.1.4 TGA 
Thermal stability of the various PU films was investigated by using TGA, and the 
percentage mass loss of various PU films at temperatures from 25°C to 650°C is shown 
in Figure 7a. The results show that the four types of PU films exhibited a similar mass 
loss profile with decomposition events began at approximately 276°C. Specifically, the 
average onset temperatures were 355.0 ± 2.1°C, 359.3 ± 1.6°C, 337.1 ± 2.0°C, and 354.2 
± 2.1°C for 60ES, 100ES, 60ET, and 200ET groups, respectively. The mass loss 
associated with the onset temperature was attributed to the dissociation of urethane 
linkages, including diisocyanates, alcohol, and amines [62]. In addition to the onset 
temperatures, there were negligible mass losses (< 0.1%) up to 250°C for the various PU 
films, suggesting that these samples contained very minimal water content [63].  
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The derivative of the mass loss in TGA profiles yields dTG curves, and the dTG 
curves are helpful in finding the peak decomposition temperatures along with the types of 
phase transitions during decomposition. As seen from the dTG curves shown in Figure 
7b, 60ES and 100ES films both displayed a single peak located at an average temperature 
of 406.1 ± 13.9°C and 433.3 ± 2.7°C, respectively. In comparison, the 60ET and 200ET 
films displayed a two-stage decomposition process with the corresponding first peak 
located at an average temperature of 385.6 ± 5.0°C and 394.1 ± 1.1°C and the 
corresponding second peak located at an average temperature of 437.8 ± 1.6°C and 439.6 
± 1.7°C, respectively. The peak decomposition temperatures with their corresponding 
percentage mass losses for 60ES, 100ES, 60ET, and 200ET are listed in Table 2. 
 
Figure 7. Thermal stability evaluations of the various PU films, showing (a) 
representative TGA curves on percentage mass loss with onset temperatures ranged 
between 337 °C to 355 °C; (b) representative dTG curves where 60ES and 100ES groups 
exhibited single peak decomposition temperature and 60ES and 200ES groups displayed 
a two-step decomposition process. 
100 200 300 400 500 600
0
20
40
60
80
100
60ES
100ES
60ET
200ET
Temperature (°C)
M
a
s
s
 (
%
)
100 200 300 400 500 600
-8
-6
-4
-2
0
60ES
100ES
60ET
200ET
Temperature (°C)
D
e
ri
v
a
ti
o
n
 M
a
s
s
 (
%
/m
in
)
(a) (b)
29 
 
Table 2. dTG temperatures and their corresponding percentage mass losses of the 
commercial PU films. 
 First Step Second Step 
 
Temperature 
(°C) 
Mass (%) 
Temperature 
(°C) 
Mass (%) 
60ES 406.1 ± 13.9 52.2 ± 4.5 - - 
100ES 433.3 ± 2.7 33.2 ± 1.6 - - 
60ET 385.6 ± 5.0 68.1 ± 1.4 437.8 ± 1.6 32.2 ± 1.6 
200ET 394.1 ± 1.1 69.0 ± 1.5 439.6 ± 1.7 34.3 ± 0.5 
 
5.1.5 XRD 
While infrared techniques are useful in observing the short-range molecular 
interactions, XRD provides information on the long-range ordering of the molecular 
chains. Additionally, XRD method is particularly suited for the determination of 
crystallinity [64] and chain orientation [65] in the segmented PU. Furthermore, 
depending on the amount of the hard and soft segments, phase separation may affect the 
structural regularity that leads to poor hemocompatibility. 
The degree of crystallinity depends on the structure of diisocyanates as they form 
the backbone of the PU. As shown Figure 8, all samples showed a broad peak at 2θ = 
20°. The board peak along with its small intensity suggested that the PU films were 
generally amorphous while carrying a small fraction of crystalline phase. The relatively 
low amount of the crystalline phase made the determination of the degree of crystallinity 
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difficult. Furthermore, aliphatic PUs typically had a sharp peak due to the aligned chain 
orientation while the aromatic PUs exhibited a much broader peak attributed to the 
amorphous structure [66]. Interestingly, the 60ET groups and the 100ES groups showed 
smaller peaks at 2θ = 21.8° indicating some level of partial crystallization of the soft 
segment [66]. The results of the XRD testing is in agreement with the results from the 
FTIR analysis. 
 
Figure 8. XRD patterns of the various PU films, showing a broad peak at 2θ = 20° 
related to semicrystalline structure of the hard/soft segments in PUs. The small peaks at 
the shoulders of the 100ES and 60ET groups were attributed to the partial crystallization 
of the soft segments. 
5.1.6 Water Content Angle and Water Absorption 
One of the most critical factors in determining hemocompatibility is a material’s 
surface hydrophilicity/hydrophobicity, and these properties are found using the water 
contact angle experiment (Figure 9a). As shown in the representative image for each PU 
film, the water droplet formed a spherical shape due to the balanced net force between 
surface hydrophobicity of the film and the surface tension of the water droplet. The 
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results indicate that the surfaces of the PU films were hydrophobic with an average water 
contact angle of 101.5 ± 0.6, 96.4 ± 1.5, 99.2 ± 1.5, and 114.0 ± 1.8 for 60ES, 100ES, 
60ET, and 200ET groups, respectively. In comparison with a glass surface (control), 
which resulted in an average water contact angle of 7.0 ± 1.5, the notably high values of 
contact angles from the PU films (p < 0.05) suggests that the PU samples were 
hydrophobic, which may be attributed to the aromatic configuration in the molecular 
structure (Figure 5). 
Water absorption determines the amount of water intake of a material over a fixed 
time interval. High rates of water absorption may cause a change in surface 
hydrophobicity, which can affect the hemocompatibility of the material. If mass is lost, 
the test provides a useful insight into the material’s degradation or dissolution. As shown 
by the results, all of the PU films exhibited a very minimal change in mass (< ± 5%) over 
a 2-week period of observation (Figure 9b). Additionally, a short-term observation was 
performed to examine the water absorption behavior in the PU films (Figure 9b inset). 
Similar to the 2-week study, the PU films showed a minimal mass change (< ± 5%) over 
2h incubation period. The results suggest that there was a minimal to negligible change in 
mass of PU films, and as a result, the PU films were stable under physiological condition 
without noticeable changes in hydrophobicity as well as degradation behaviors. 
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Figure 9. (a) Water contact angle study on the various commercial PU films comparing 
to a glass control. (b) Water absorption and/or degradation study on various commercial 
PU films over 14 days. Figure inset shows short-term study up to 2 h. 
5.1.7 Mechanical Properties 
Another critical factor when considering a material for the potential use of 
anticoagulation coatings on implantable devices is the material’s mechanical properties. 
When introducing devices, such as cardiovascular stents, into the body, the shear force 
produced by the blood flow may cause coatings to degrade if they have inadequate 
strength. A more significant concern is that, once vascular stents are inserted into the 
body, they are required to expand and attach to the blood vessel. Therefore, coatings 
lacking sufficient elasticity are not suitable for anticoagulation applications. 
The mechanical properties of the PU films were determined with tensile testing 
performed with an Instron materials tester with a force transducer under a constant strain 
rate in order to evaluate their mechanical properties. Stress-strain data acquired from the 
raw data during tensile testing was utilized to inform the chemical structure of the 
material [67]. A representative stress-strain curve for the 200ET film is shown in Figure 
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10a, and the stress-strain curves of the other PU films tested are similar to the 
representative curve.  
An initial linear viscoelastic region can be seen on the stress-strain curve where 
the stress increase is proportional to the strain increase. After the linear viscoelastic 
region, stress increases minimally with increasing of strain (~ 400% strain). This region 
is associated with the unfolding of the soft segments. Since the PU components are more 
aromatic than aliphatic, the unfolding of the soft segments creates large amounts of 
strain. After the unfolding region, a strain-hardening region can be found where the 
significant stress increases are accompanied with the strain increase. This behavior is 
associated with the stretching of the molecular bonds that yields a much higher stress. 
The stress-strain curve shows that the PU films display a rubber-like behavior with three 
distinctive regions [68], as supported by the DSC data (Figure 6). 
Information regarding the elastic modulus can be observed from the initial region, 
which is the slope at the beginning of the curve. The average moduli of the PU films are 
shown in Figure 10b, and are 53.8 ± 0.9 MPa, 20.0 ± 1.0 MPa, 21.9 ± 2.6 MPa, and 21.0 
± 0.9 MPa for the 60ES, 100ES, 60ET, and 200ET groups, respectively. The average 
modulus of the 60ES groups appears to be more than double that of the other films, 
suggesting that the material is intrinsically different than the others (e.g., crosslinking 
[69], hard/soft segment ratio [70], or types of hard/soft segments [71]). 
Unfolding of the entangled molecular chain in the second region, primarily from 
the soft segments, can be obtained from the average elongation to failure. This property 
corresponds to the overall percentage of deformation that was applied to the material 
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before failure, and it is shown in Figure 10c. As shown in the figure, the average 
percentage elongation to failure was 482.4 ± 19.4%, 746.3 ± 37.9%, 768.7 ± 19.7%, and 
794.9 ± 22.0% for the 60ES, 100ES, 60ET, and 200ET groups, respectively. These values 
match the finding from the elastic moduli, where the 60ES group displays a decrease in 
average percent elongation to failure of about 60% compared to the other films. This 
observation suggests that the 60ES groups are less elastic than other groups, suggesting 
the potential effects on crosslinking, different hard/soft segment ratios, or types of 
hard/soft segments used in the films. 
The last region of the stress-strain curve is associated with the strain-hardening 
effect, and this phenomenon is quantified by the tensile strength of the material, which is 
found at the peak of the curve, the point at which the material fails. The average tensile 
strength of the PU films investigated is found in Figure 10d, and is 46.7 ± 3.7 MPa, 42.6 
± 3.4 MPa, 26.9 ± 3.4 MPa, and 42.9 ± 1.8 MPa for the 60ES, 100ES, 60ET, and 200ET 
films, respectively. While the 60ES, 100ES, and 200ET films display similar tensile 
strengths, the 60ET films appear to be noticeably weaker than the others (p < 0.05). In a 
study, the decrease in tensile strength was attributed to the steric hindrance of the 
increased concentration of the side dimethyl and methyl groups [72]. Under constant 
strain, soft segment chains can be stretched and crystallized. This steric hindrance on the 
restriction of chain crystallization resulted in the decrease of the available sites for 
crosslinking and yielded a relatively low degree of microphase separation. This theory is 
supported by the DSC data of 60ET and 200 ET, where a melting of the soft segment was 
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found in 200 ET rather than the 60ET groups (Figure 6). Therefore, a decrease of tensile 
strength in the 60ET can be largely associated with this theory. 
 
Figure 10. Mechanical properties of the various PU films, showing (a) a representative 
engineering stress-strain curve from 200ET groups; (b) average elastic moduli; (c) 
average elongation to failure; (d) average tensile strength. 
5.1.8 Clotting Assays 
As the intended purpose for the PU films is for use as anticoagulation coatings on 
implantable devices, the hemocompatibility of the PU films has to be evaluated. There 
are various studies showing that polyurethane is ideal for anticoagulant usage [73–75]. 
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Therefore, in this section, the hemocompatibility of each PU film is evaluated by 
determining the rate of clotting when in contact with human blood plasma. 
To find the clotting time, an in vitro clotting assay was initiated by placing a 
droplet of human blood plasma on the surfaces of the PU films in comparison with the 
surface of the glass control group (Figure 11a). Immediately after the contact with the PU 
surfaces (i.e., 0 min contact time), the clotting times were 138 ± 16 s, 169 ± 4 s, 149 ± 3 
s, and 154 ± 2 s for 60ES, 100ES, 60ET, and 200ET films, respectively. These clotting 
times showed no statistical significance when compared to the glass control group (p > 
0.05). At 10 minutes of contact time, the clotting time for the glass control group was 98 
± 11 s, whereas the clotting times for the PU films were 160 ± 17 s, 167 ± 2 s, 145 ± 19 s, 
and 163 ± 4 s for 60ES, 100ES, 60ET, and 200ET films, respectively. At the end of the 
assay (i.e., 22 min contact time), the plasma on the glass surface had clotted completely. 
In comparison, the clotting times of the PU films were 131 ± 67 s, 156 ± 6 s, 154 ± 20 s, 
and 162 ± 7 s for 60ES, 100ES, 60ET, and 200ET films, respectively. The results show 
that the PU films displayed excellent hemocompatibility with minimal change in the 
clotting time at fixed contact intervals up to 22 min. 
In the first clotting assay, 40 μL of CaCl2 were added to the plasma to activate the 
coagulation cascade by interacting with clotting factors, where the contact surface (e.g., 
the PU films or glass control) acted as the enabling substances [76]. Therefore, the 
concentration of the CaCl2 played an important role in evaluating the rate of clot 
formation. To see the effects of CaCl2 on the clotting time, an additional in vitro clotting 
assay was performed using 20 – 50 μL of CaCl2 on 100ES, 200ET, and glass control 
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groups with 10 minutes of contact time (Figure 11b). Increasing calcium concentration 
from 20 to 50 μL decreased the clotting times from 143 ± 3 s to 23 ± 1 s when the plasma 
was placed on the surface of glass control group. In contrast, the clotting times for 100ES 
and 200ET films were 172 ± 2 s and 167 ± 3 s at 20 μL of CaCl2 and were 167 ± 5 s and 
166 ± 4 s at 50 μL of CaCl2, respectively. Results suggest that calcium promoted clot 
formation, where the control group exhibited a dependence on the calcium concentration 
and the PU groups displayed an excellent degree of hemocompatibility. 
The first in vitro clotting assay was performed under laboratory conditions where 
the plasma would dry out after 25 minutes. This assay limited the contact time to be no 
more than 22 minutes and combining with the CaCl2 concentration assay with a 
maximum level of CaCl2 in the 50 μL to 60 μL range, clotting due to the PU as an 
activating substance was unable to quantify. For this reason, a second in vitro clotting 
assay was performed where samples (plasma + activating substances) were placed into 
Eppendorf tubes that allowed for storage to up to 4 weeks or longer. At fixed time 
periods, a sample of plasma was taken out of the tube and placed into the coagulation 
analyzer to record the clotting time (Figure 11c). Using this assay, the clotting times of 
the PU films displayed a decrease of clotting time with a contact time that was 1000-fold 
longer than the glass control surface. Specifically, the clotting times were 63.3, 81.4, 
45.8, and 48.9 s for 60ES, 100ES, 60ET, and 200ET films after 4 weeks of contact time 
(672 h), respectively. This result is notable because while the first clotting assay showed 
that the PU films displayed better hemocompatibility than the glass control, the length of 
contact time of the PU films was determined in the second in vitro clotting assay. 
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Various studies expressed that modified PUs displayed anticoagulant properties. 
For example, water-soluble chitosan/dextran sulfate was immobilized onto PU films and 
the clotting time was 670% longer than the native PU after 30 min of contact time [77]. 
Others added heparin into PU films to allow for slow heparin delivery [78]. Results 
showed that heparin-eluting PU films displayed clotting times greater than 200 s after 30 
days of contact time. More importantly, the control PU films showed a clotting time of 
46.8 s after the same contact time, and the results obtained with the commercial films are 
in agreement with the reported value. Furthermore, poly(ethylene glycol) monoacrylates 
(PEG-MAs) were grafted onto polycarbonateurethane films to increase the hydrophilicity 
of the films, which suppressed platelet adhesion to improve hemocompatibility [79]. In 
general, the results showed that the commercial PU films studied displayed excellent 
anticoagulant properties that were ideal for use as anticoagulation coatings on artificial 
organs and/or implantable devices to minimize clot formation. 
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Figure 11. In vitro clotting assays on the various PU films in comparison with the glass 
control, showing (a) clotting assay (1) where human blood plasma were placed on the 
surface of the activating substances; (b) effects of CaCl2 concentrations on the clot times 
using clotting assay (1); (c) clotting assay (2) where human blood plasma and the 
activating substances were placed in an enclosure. 
5.2 Films Synthesized In Lab 
5.2.1 Synthesis 
PU samples synthesized in the lab were carried out by step polymerization of 
PEG (soft segment) and TDI (hard segment) to form urethane linkages. In order to allow 
homogeneous mixture of the two polymer solutions, DMF was used to dissolve the PEG 
followed by slowing adding TDI solution into the PEG-containing DMF solvent. The 
resulting polymer mixture was slightly viscous with yellowish appearance and was free 
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of phase separation. After 3 hours of mixing at 75 °C, the polymer mixture was poured 
into DI-water to allow precipitation of the PU. The first two PU samples successfully 
precipitated in the lab in a trial-and-error effort based on the stoichiometric ratio of PEG-
to-TDI consisted of the same PEG:TDI molar ratio (1:157). 
After the successful precipitation of the PU samples from PEG:TDI mixture, the 
next several attempts were made using a 1:4 ratio; however, this mixture was unable to 
precipitate fully, suggesting a limitation on step polymerization efficiency between the 
PEG (soft segment) and the TDI (hard segment). To investigate the range of possible 
PEG:TDI ratios, four more samples were then successfully synthesized and precipitated, 
with ratios of 1:20, 1:40, 1:80, and 1:160 (PEG:TDI), to be used for testing and 
characterizations. The appearances of these precipitated samples can be seen in Figure 12 
with variations in color due to the amount of PEG in the system. 
 
Figure 12. PU samples synthesized and precipitated in the lab at various PEG:TDI ratios, 
including 1:20, 1:40, 1:80, and 1:160, using step polymerization. 
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5.2.2 Yield Mass 
PU synthesis using step polymerization in the lab was performed at a fixed 
volumetric amount of PEG (i.e., 15 wt% of PEG in 8 ml of DMF) where the amount of 
TDI increased from 1:20 to 1:160. The observation on the production of synthesized PU 
samples, shown in Figure 12, suggested an increase in the productivities of PU with 
increasing PEG:TDI ratios. A series of charaterizations on the PU synthesis from PEG 
and TDI were performed on the reaction temperatures as well as PU yield in order to 
determine the process conditions for various PEG:TDI ratios. 
 During the synthesis of the initial four samples, it was discovered that the duration 
required for the solution mixture needed to be decreased with lower ratios of PEG:TDI. 
Over time, the viscosity of the lower ratios of PEG:TDI solution mixtures increased with 
several of the lower ratios of PEG:TDI samples thickening to the point that the stir bar 
was immobilized. While this effect was independent of solution’s ability to be able to 
precipitate, the synthesis process of PU samples at lower ratios of PEG:TDI became more 
difficult with less ability to quality control the appearance of the PU samples. This lead to 
the creation of a standard curve for the heating time, shown in Figure 13, used for each 
ratio in order to reduce the chance for the sample to thicken too much for the 
precipitation process. 
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Figure 13. Standard heating times for the step polymerization of the PU samples from 
mixtures of PEG:TDI at different ratios. 
 
 After the creation of the standard curve for the heating time, synthesis of the PU 
samples was standardized from batch to batch to minimize sample differences within the 
same PEG:TDI ratio. Measurements on the yield mass of the produced PU sample at 
various ratio was evaluated and plotted in Figure 14. As expected, the yield mass 
increased at a steady rate from an average of 3.13 g to 11.1 g when the ratio of PEG:TDI 
increased from 1:20 to 1:80. However, as the ratio of PEG:TDI continued to increase 
from 1:80 to 1:160, the average yield mass in the precipitated PU only increased from 
11.1 g to 13.3 g. These results suggested that synthesis of PU from PEG and TDI 
exhibited a linear region for the step polymerization followed by a decrease in the 
production rate that eventually reached stabilization of the process irrespective of the 
increase of TDI in the PEG:TDI mixture. 
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Figure 14. The relationship of yield mass obtained from the precipitated PU samples and 
the PEG:TDI ratios in the mixture for step polymerization. 
 
5.2.3 Physical Appearance and Characteristics 
The synthesized PU samples were then solvent cast into films for comparisons of 
their physical and mechanical properties with the commercial films. A total of eight sets 
of samples, including PEG:TDI ratios of 1:20, 1:40, 1:80, and 1:160 that were formulated 
with and without a chain extender (i.e., BDO), were prepared and evaluated first with 
their physical appearances. 
The observations suggested that different ratios of PEG:TDI had an effect on the 
physical appearance and characteristics of the films as shown in Figure 15 illustrating the 
synthesized PU films at various PEG:TDI ratios without BDO. For example, the 1:20 
films, shown in Figure 15a, were thinner and far more flexible than the other films. The 
1:20 films tore easily while being removed from the molds, therefore requiring much 
more time and care. The 1:40 and 1:80 films, shown in Figure 15b and 15c respectively, 
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had very similar physical appearances and characteristics. The main difference between 
the two films was that the 1:80 films were slightly more brittle, which was expected due 
to a higher content of the hard segment (TDI) in the film as compared to the 1:40 films. 
The 1:160 films, shown in Figure 15d, were thick and brittle in addition to the appearance 
of several air bubbles throughout most of the samples. 
The samples that contained BDO looked similar to their counterparts, and the 
main difference was that the 1:160 BDO films exhibited noticeably less air bubbles on 
the surface or within the sample itself as compared to those without BDO. For the 
duration of the study, the films were stored under typical laboratory conditions (e.g., 23 ± 
2 °C and 50 ± 5% RH) and exhibited no signs of degradation and/or changes in 
appearance. 
 
Figure 15. Physical appearance of the synthesized PU films at different ratios of 
PEG:TDI without the chain extender BDO: (a) 1:20, (b) 1:40, (c) 1:80, and (d) 1:160 
(PEG:TDI) ratio. 
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5.2.4 FTIR Analysis 
The FTIR spectra of the PU films without the inclusion of the chain extender 
(BDO) are shown in Figure 16. The lab-synthesized PU films exhibited characteristic 
peaks that were similar to those of the commercial films. For example, FTIR spectra of 
the lab-synthesized PU samples showed the characteristic peaks of N–H stretching 
vibration at around 3300 cm-1 and C=O stretching vibration from amide I band at around 
1700 cm-1. Also, the characteristic peaks of N–H bending vibration from amide II band at 
around 1530 cm-1 and C–N stretching vibration from amide III band at around 1310 cm-1 
that form the urethane linkage (–NHCO–) are shown. The main difference between the 
commercial films and the lab-synthesized samples is that the peak at around 3300 cm-1 
was not as defined for the lab-synthesized PU samples. This could be attributed to the 
presence of moisture, as the synthesis process of PU in the lab was not carried out under a 
nitrogen blanket that was generally recommended.  
 
Figure 16. FTIR spectra of the synthesized PU samples for wavenumbers from 700 cm-1 
to 4000 cm-1 showing the characteristic peaks of N–H stretching vibration at around 3300 
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cm-1 and C=O stretching vibration from amide I band at around 1700 cm-1, as well as 
wavenumbers from 1000 cm-1 to 1600 cm-1 showing the characteristic peaks of N–H 
bending vibration from amide II band at around 1531 cm-1 and C–N stretching vibration 
from amide III band at around 1314 cm-1 that form the urethane linkage (–NHCO–). 
5.2.5 Water Content Angle Studies 
The results of water contact angle tests on the lab-synthesized PU films, shown in 
Figure 17, indicated that the surfaces of the films were hydrophobic similar to the 
commercial films. In particular, the average water contact angle of lab-synthesized PU 
films without chain extender (BDO) decreased from 112.3 ± 4.7, 99.5 ± 3.6, 99.6 ± 5.1, 
to 93.4 ± 1.9 as the TDI content increased from 1:20, 1:40, 1:80, and 1:160, respectively. 
In contrast, the average water contact angle of lab-synthesized PU films with chain 
extender (BDO) increased from 96.6 ± 4.3, 98.7 ± 4.9, 96.9 ± 2.0, to 103.0 ± 3.1 as the 
TDI content increased from 1:20, 1:40, 1:80, and 1:160, respectively. In comparison with 
the glass surface (control) that was compared to the commercial PU films, which resulted 
in an average water contact angle of 7.0 ± 1.5 (Figure 9a), the notably high values of 
water contact angles from the lab-synthesized PU films suggested that the PU samples 
were hydrophobic. The main difference between the films with and without the chain 
extender (BDO) was that the films with no BDO had slightly higher contact angles with 
the exception of the 1:160 films, though this could be attributed to the air bubbles on the 
surface of the 1:160 films without BDO creating an uneven surface. The higher angles 
could suggest that the films without BDO were slightly more hydrophobic than those 
with the chain extender, which could potentially exhibit anticoagulant ability. 
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Figure 17. Water contact angle study on the various lab-synthesized PU films. 
 
5.2.6 Water Absorption and Degradation Studies 
Lab-synthesized PU samples, with and without chain extender (BDO), were 
incubated in DI-water at 37 °C for up to 2 weeks to evaluate water absorption behaviors 
and polymer degradation ability. During the incubation, all lab-synthesized PU films 
without chain extender (BDO) exhibited a very minimal change in mass (< ± 5%) over a 
2-hour period of observation (Figure 18a). The 1:20, 1:40, and 1:80 similarly displayed 
very minimal change in mass (< ± 5%) over a 2-week period of observation (Figure 18b). 
However, the 1:160 films showed small changes in mass over the 2-week period and the 
1:80 films lost about 10% of its mass before Day 2 during the 2-week incubation period. 
For these films, the results suggested that there was a minimal to negligible change in 
mass of the 1:20 and 1:40 PU films, and as a result, the PU films using these ratios were 
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stable under physiological condition without noticeable changes in hydrophobicity as 
well as degradation behaviors. 
 
Figure 18. (a) Short-term water absorption and/or degradation study on the lab-
synthesized PU films without BDO over 2 hours. (b) Long-term water absorption and/or 
degradation study on the lab-synthesized PU films without BDO over 14 days. 
 
For the lab-synthesized PU samples with chain extender (BDO), all of the PU 
films exhibited a very minimal change in mass (< ± 5%) over a 2-hour period of 
observation (Figure 19a). However, all of the PU films experienced some degree of 
change in mass (> ± 5%) over a 2-week period of observation (Figure 19b). For these 
films, the results suggested that there was a significant change in mass of all PU films 
with BDO, and as a result, these were not stable under physiological condition. 
The results of these tests show that, for very short-term applications, adding the 
chain extender will not cause a significant change in the water absorption or degradation 
properties of the PU films under physiological conditions. However, for applications that 
will exceed a few days, adding the chain extender to the PU films causes them to become 
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unstable under physiological conditions, which is not desirable for use in anticoagulation 
coatings on implantable biomedical devices. 
 
Figure 19. (a) Short-term water absorption and/or degradation study on the lab-
synthesized PU films with BDO over 2 hours. (b) Long-term water absorption and/or 
degradation study on the lab-synthesized PU films with BDO over 14 days. 
 
5.2.7 Mechanical Properties 
Figure 20 shows the representative stress-strain curves for the lab-synthesized PU 
films without BDO. The 1:20 films shown in Figure 20a exhibited similar stress-strain 
behaviors to the commercial films. In general, the stress-strain curves of the 1:20 samples 
displayed a wider initial linear viscoelastic region followed by a shorter unfolding region 
(~ 120% strain), which was associated with the unfolding of the soft segment that creates 
a large amount of strain, than the commercial films. After the unfolding regions, the lab-
synthesized 1:20 films showed a strain-hardening region, similar to the commercial films, 
that was associated with the stretching of molecular bonds that yields much higher 
increases in stress with the increasing strain. The stress-stain behaviors of other lab-
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synthesized PU films were shown in Figure 20b. The 1:40 film exhibited an initial 
viscoelastic region and a very short unfolding region (~14% strain) before failure, which 
was expected due to the high content of the hard segment. This trend continued with the 
1:80 and 1:160 films, which exhibited the initial viscoelastic region but fail at much 
smaller strain as these films became very brittle. 
 
Figure 20. Representative engineering stress-strain curves of the various lab-synthesized 
PU film ratios without BDO: (a) All ratios, (b) 1:40, 1:80, and 1:160 films. 
 
Figure 21 showed the representative stress-strain curves for the lab-synthesized 
PU films with chain extender (BDO). All of the ratios were virtually identical to those 
without BDO. The stress-strain curve of the 1:20 films with BDO shown in Figure 21a 
exhibited the characteristics of less semicrystalline than the counterpart due to the 
necking behavior near yielding. Nonetheless, the stress-stain behavior included a wide 
initial viscoelastic region, a short unfolding region (~80% strain), and a strain-hardening 
region. The stress-strain behaviors of other films were shown in Figure 21b, which 
displayed characteristics of brittle materials as the hard segment ratio increases. This 
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finding was similar to the films without the chain extender. Overall, the only significant 
difference between the films with and without the chain extender (BDO) was that the 
1:20 films without BDO had a noticeably higher elongation to failure, which suggested 
that the addition of the chain extender reduced the flexibility of the PU to a small degree. 
This finding was consistent with other studies regarding the addition of a diol chain 
extender to PU containing TDI as the hard segment [80]. 
 
Figure 21. Representative engineering stress-strain curves of the various lab-synthesized 
PU film ratios with BDO: (a) All ratios, (b) 1:40, 1:80, and 1:160 films. 
 
The average elastic moduli of the lab-synthesized PU films without BDO, shown 
in Figure 22a, were 4.5 ± 1.6 MPa, 13.9 ± 2.5 MPa, 13.9 ± 3.2 MPa, and 12.0 ± 3.0 MPa 
for the 1:20, 1:40, 1:80, and 1:160 films, respectively. Furthermore, the average elastic 
moduli of the lab-synthesized PU films with BDO were 1.8 ± 0.2 MPa, 10.3 ± 3.5 MPa, 
10.1 ± 0.7 MPa, and 10.2 ± 2.4 MPa for the 1:20, 1:40, 1:80, and 1:160 films, 
respectively. The average elastic modulus of the 1:20 films were less than half that of the 
other ratios and were, therefore, far more flexible. Also, all of the films that contain BDO 
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have a noticeably lower elastic modulus than their non-BDO counterparts, which was 
consistent with other studies that suggested the decrease of elastic modulus and tensile 
strength due to the addition of BDO [81]. 
The average tensile strength of the lab-synthesized PU films without BDO, shown 
in Figure 22b, were 35.2 ± 1.7 MPa, 44.8 ± 9.1 MPa, 43.7 ± 6.2 MPa, and 37.9 ± 1.8 
MPa for the 1:20, 1:40, 1:80, and 1:160 films, respectively. Furthermore, the average 
tensile strength of the lab-synthesized PU films with BDO were 20.3 ± 7.1 MPa, 32.9 ± 
10.6 MPa, 37.0 ± 4.3 MPa, and 38.0 ± 9.8 MPa for the 1:20, 1:40, 1:80, and 1:160 films, 
respectively. For the films without BDO, the 1:40 and 1:80 were noticeably stronger than 
the 1:20 and 1:160 films. This was expected for the 1:20 due to the decreased content of 
the hard segments. In addition, decrease in strength for the 1:160 films was most likely 
associated with imperfections, such as air bubbles, along the surface of the films. The 
BDO films had a slightly lower tensile strength, which was consistent with other studies 
[81]. Tensile strength of the BDO containing samples increased in a more linear fashion 
than the non-BDO samples since the films contained less imperfections (e.g., air bubbles) 
along the surface of the films. 
The average percentage elongation to failure of the lab-synthesized PU films 
without BDO, shown in Figure 22c, were 230.7 ± 47.9%, 9.2 ± 3.9%, 5.7 ± 2.3%, and 7.6 
± 2.4% for the 1:20, 1:40, 1:80, and 1:160 films, respectively. Furthermore, the average 
percentage elongation to failure of the lab-synthesized PU films with BDO were 145.7 ± 
60.6%, 8.3 ± 3.0%, 7.9 ± 0.3%, and 8.6 ± 4.4% for the 1:20, 1:40, 1:80, and 1:160 films, 
respectively. These values matched the finding from the elastic moduli, where the 1:20 
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group displays a significant increase in average percent elongation to failure compared to 
the other films. This observation suggested that the 1:20 films were far more elastic than 
other groups, which was expected. The only significant difference, as noted earlier, was 
the noticeable decrease in elongation to failure of the 1:20 with BDO film compared to 
the 1:20 film without BDO, which was consistent with the addition of a diol chain 
extender to a TDI-based PU as shown in other studies [80]. 
 
Figure 22. (a) Average elastic moduli of the various lab-synthesized PU film ratios, with 
and without BDO. (b) Average tensile strength of the various lab-synthesized PU film 
ratios, with and without BDO. (c) Average elongation to failure of the various lab-
synthesized PU film ratios, with and without BDO. 
 
5.2.8 Comparison to Commercial Films 
 As all of the other lab-synthesized films were shown to be unstable under 
physiological conditions, the 1:20 and 1:40 films without BDO are the only films suitable 
for use in anticoagulant coatings. Table 3 shows a comparison of the properties of these 
films compared to the commercial films. Both lab films had similar tensile strengths to 
the commercial films, however, both had lower elastic moduli. The 1:40 film had a 
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significantly lower elongation to failure, while the 1:20 film had the closest value to those 
of the commercial films, though it was still much lower. With modifications to the lab 
films, it should be possible to optimize their properties to get them closer to those of the 
commercial films. 
 
Table 3. Comparison of mechanical properties of the commercial films to the lab films. 
Films 
Elastic Modulus 
(MPa) 
Tensile Strength 
(MPa) 
Elongation to 
Failure (%) 
1:20 No BDO 4.5 ± 1.6 35.2 ± 1.7 230.7 ± 47.9 
1:40 No BDO 13.9 ± 2.5 44.8 ± 9.1 9.2 ± 3.9 
60ES 53.8 ± 0.9 46.7 ± 3.7 482.4 ± 19.4 
100ES 20.0 ± 1.0 42.6 ± 3.4 746.3 ± 37.9 
60ET 21.9 ± 2.6 26.9 ± 3.4 768.7 ± 19.7 
200ET 21.0 ± 0.9 42.9 ± 1.8 794.9 ± 22.0 
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Chapter 6: Conclusions and Future Work 
In this work, the viability of polyurethane films for potential use as 
anticoagulation coatings on implantable medical devices was examined. Four commercial 
films, two polyester urethane films and two polyether urethane films, of various 
thicknesses and shore hardness were purchased and tested to determine their chemical, 
thermal, physical, and mechanical properties, as well as evaluating their anticoagulant 
abilities. The FTIR analysis of the commercial PU films showed the presence of 
characteristic chemical bonds, confirming that the films included both polyester- and 
polyether-urethanes. However, the specific materials used to synthesize the commercial 
films is still unknown.  
The DSC and TGA testing displayed the thermal stability and properties of the 
films. XRD analysis, along with DSC, displayed the crystallinity of the films, as well as 
the chain orientation. The water contact angle results exhibited the hydrophobicity of the 
films and the absorption/degradation tests showed that the films experienced no 
significant change in mass. The mechanical testing displayed the high degree of elasticity 
of the films and great tensile strength. The elasticity of the films, along with their lack of 
degradation, means that the films fulfill the necessary mechanical properties for use in 
applications like stent coatings. Finally, the results of the second clotting assay showed 
that the films are capable of delaying the onset of clot formation to a significant degree. 
The results gathered through all of the testing performed on the commercial films 
showed that polyurethane films had excellent thermal and physico-mechanical properties 
for use in anticoagulant coatings and are capable of increasing contact time by a 
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thousand-fold compared to a control. However, the lack of knowledge regarding the 
specific composition and structure of the commercial films means that vital properties, 
such as the long-term biocompatibility of the films, could not be easily determined or 
modified. Therefore, samples were synthesized in-house to be used for further research. 
The samples were synthesized with a range of different hard-to-soft segment ratios in 
order to optimize the properties of the final products. 
PEG and TDI were chosen as the soft and hard segments, based on the 
biocompatibility of PEG and the mechanical properties of TDI, and samples of several 
ratios were successfully synthesized, as confirmed from the FTIR results. Several ratios 
were used in order to find which ratio produced a film with optimal properties for the 
intended purpose. The hard-to-soft segment ratios chosen were 1:20, 1:40, 1:80, and 
1:160, based on initial attempts to synthesize and precipitate the polyurethane, as well as 
to examine how these ratios would affect the physico-mechanical properties of the films 
produced. Another set of films with these ratios that included BDO as a chain extender 
was also synthesized to examine how it further affected the properties of the films 
While it was expected that the ratios would affect the physico-mechanical 
properties of the films, it was noted during the synthesis process that yield mass, physical 
appearance, and the mixing time necessary when preparing the polymer were also 
affected. Higher ratios of the hard-to-soft segments had a higher yield mass and required 
a longer mixing time. Also, the higher ratio films, mainly the 1:160 group, caused several 
issues during the synthesis process, as air bubbles and cracking was a constant problem 
with these films. 
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Water contact angle testing performed on the lab-synthesized films showed that 
all were hydrophobic. The water absorption/degradation study on these films displayed 
that most of the films experienced a significant change in weight over a two-week period 
and were, therefore, hydrolytically unstable under physiological conditions. The only 
films that exhibited no significant mass change were the 1:20 and 1:40 films that did not 
contain BDO. The mechanical testing results showed that all of the films exhibited great 
tensile strength, but the 1:20 films were, by far, the most elastic. 
For anticoagulation coatings on implantable biomedical devices, the 1:20 PU 
films without BDO exhibited the best physico-mechanical properties compared to the 
other ratios. While the 1:40 ratio also exhibited viable properties for the application, it 
lacked the elasticity necessary for certain devices, such as cardiac stents that have to 
expand. All other ratios experienced too much hydrolytic instability under physiological 
conditions to be considered. 
 For future work, it is suggested to perform clotting assays and degradation studies 
over a much longer time interval in order to evaluate the effective lifetime of the 1:20 
films, as well as to determine if cytotoxicity becomes an issue due to the aromatic 
components in the films. It is also suggested to explore and evaluate different surface 
modifications that could help prevent hydrolytic degradation and to further lengthen 
clotting times. 
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